JHOP Articles

Skip to main content

Meeting Highlights

ASH Highlights

Immune Responses to COVID-19 Vaccines Low Among Patients with Hematologic Malignancies, but mRNA Vaccines Induce Strong Antibody Response in AML and MDS

Review Article, CAR T-Cell Therapy, Lymphoma

A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas

Drew A. Wells, PharmD, BCPS, Jenna Summerlin, PharmD, Zachery Halford, PharmD, BCOP, BCPPS

Drew A. Wells, PharmD, BCPS; Jenna Summerlin, PharmD; Zachery Halford, PharmD, BCOP, BCPPS

Case Reports, Leukemia, Adverse Events

Dasatinib-Induced Gynecomastia in 2 Patients with Chronic Myeloid Leukemia: Case Reports and Review of the Literature

Jessie Signorelli, PharmD, BCOP, Amir T. Fathi, MD, Gabriela Hobbs, MD

Jessie Signorelli, PharmD, BCOP; Amir T. Fathi, MD; Gabriela Hobbs, MD

Case Reports, Breast Cancer, Adverse Events

Spontaneous Tumor Lysis Syndrome in a Patient with Stage IV HER2-Positive Breast Cancer: Case Report

Blake T. Robbins, PharmD, MBA , Alexander M. Kreimer, PharmD, BCPS , Reema A. Patel, MD, Allison R. Butts, PharmD, BCOP

Blake T. Robbins, PharmD, MBA; Alexander M. Kreimer, PharmD, BCPS; Reema A. Patel, MD; Allison R. Butts, PharmD, BCOP

Original Research, Pediatric Cancer, Leukemia, Lymphoma

Lidocaine plus Tetracaine–Medicated Patch Used for Propofol Sedation During Lumbar Punctures in Pediatric Patients with Blood Cancer

Lisa R. Garavaglia, PharmD , Frank Casey, MD, Lesley Cottrell, PhD, Claudiu Faraon-Pogaceanu, MD, Stephan Paul, MD, Melvin Lee Wright, DO

Lisa R. Garavaglia, PharmD; Frank Casey, MD; Lesley Cottrell, PhD; Claudiu Faraon-Pogaceanu, MD; Stephan Paul, MD; Melvin Lee Wright, DO

First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma

Peer Reviewers

Thank You JHOP Peer Reviewers

Chronic Lymphocytic Leukemia

Helping Patients Navigate Their Journey with Chronic Lymphocytic Leukemia

Multiple Myeloma, Monoclonal Antibodies

Phase 1/2 Study Results of BCMA x CD3 Bispecific Monoclonal Antibody REGN5458 in Patients with RRMM

Multiple Myeloma

Phase 1b TRIMM-2 Trial Results for Subcutaneous Talquetamab plus Daratumumab in Patients with RRMM

Page 57 of 196
Results 561 - 570 of 1953